Author

Charles E. Mowbray

Drugs for Neglected Diseases InitiativeORCID 0000-0003-3538-8116Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Assay:metagenomics· 1 Organism:virus· 1

Frequent Co-Authors

Antoine NougaırèdeiD· 1 shared Eric ChatelainiD· 1 shared Fanny EscudiéiD· 1 shared Franck TouretiD· 1 shared Géraldine PiorkowskiiD· 1 shared Hawa Sophia Bouzidi· 1 shared Ivan ScandaleiD· 1 shared Jean‐Sélim DriouichiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Antoine NougaırèdeORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

MicrobiologyAntiviral ResearchPeer-reviewedJan 23, 2024

Generation and evaluation of protease inhibitor-resistant SARS-CoV-2 strains

Hawa Sophia Bouzidi, Jean‐Sélim Driouich, Raphaëlle Klitting…·Franck Touret

The paper generates and evaluates SARS-CoV-2 mutants resistant to protease inhibitors nirmatrelvir and ensitrelvir, showing in vitro and in vivo resistance and linking M49L mutation prevalence to Xocova(R) use.

28 citationstop 1%

virusmetagenomics

𝕏 PostBluesky